Home
>
National Drug Code (NDC)
>
CYCLOPHOSPHAMIDE
CYCLOPHOSPHAMIDE - 10019-990-01 - (Cyclophosphamide)
Drug Information of CYCLOPHOSPHAMIDE
| Product NDC: | 10019-990 |
| Proprietary Name: | CYCLOPHOSPHAMIDE |
| Non Proprietary Name: | Cyclophosphamide |
| Active Ingredient(s): | 2 g/100mL & nbsp; Cyclophosphamide |
| Administration Route(s): | INTRAVENOUS; ORAL |
| Dosage Form(s): | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of CYCLOPHOSPHAMIDE
| Product NDC: | 10019-990 |
| Labeler Name: | Baxter Healthcare Corporation |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA012142 |
| Marketing Category: | NDA |
| Start Marketing Date: | 19591116 |
Package Information of CYCLOPHOSPHAMIDE
| Package NDC: | 10019-990-01 |
| Package Description: | 1 VIAL, SINGLE-DOSE in 1 CARTON (10019-990-01) > 100 mL in 1 VIAL, SINGLE-DOSE |
NDC Information of CYCLOPHOSPHAMIDE
| NDC Code | 10019-990-01 |
| Proprietary Name | CYCLOPHOSPHAMIDE |
| Package Description | 1 VIAL, SINGLE-DOSE in 1 CARTON (10019-990-01) > 100 mL in 1 VIAL, SINGLE-DOSE |
| Product NDC | 10019-990 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Cyclophosphamide |
| Dosage Form Name | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
| Route Name | INTRAVENOUS; ORAL |
| Start Marketing Date | 19591116 |
| Marketing Category Name | NDA |
| Labeler Name | Baxter Healthcare Corporation |
| Substance Name | CYCLOPHOSPHAMIDE |
| Strength Number | 2 |
| Strength Unit | g/100mL |
| Pharmaceutical Classes | Alkylating Activity [MoA],Alkylating Drug [EPC] |
